J&J Finishes Tough Year With Optimism For 2021
J&J expects its medical device sales to begin growing rapidly by the middle of 2021 as the pandemic subsides.
You may also be interested in...
Numbers of COVID-19 patients in the hospital are rising in many states and a few hospitals have been stretched to their limit, but data compiled by Credit Suisse suggests that the surgical capacity of US hospitals will stabilize in September.
Johnson & Johnson’s medical device sales were up nearly 60% year-over-year in the second quarter of 2021 while Abbott reported 51% growth in its device business, reflecting the recovery in procedure volumes since the worst days of the pandemic in mid-2020.
CMR Surgical has raised $600m to globally commercialize its Versius surgical robotics platform.